期刊文献+

EB病毒在儿童白血病患者中的感染状况及其临床意义——附35例报告 被引量:3

Infection Status and Clinical Significance of Epstein-Barr Virus in Pediatric Leukemia——A Report of 35 Cases
暂未订购
导出
摘要 背景与目的:Epstein-Barr病毒(EBV)与多种肿瘤的发生密切相关,为此我们探讨在儿童白血病中EBV的感染及其临床意义。方法:采用荧光定量聚合酶链反应(fluorescencequantitative-polymerasechainreaction,FQ-PCR)技术,检测35例儿童白血病[其中急性淋巴细胞白血病(acutelymphoblasticleukemia,ALL)26例(初治24例,复治2例);急性非淋巴细胞性白血病(acutenonlymphocyticleukemia,ANLL)8例;慢性淋巴细胞性白血病(chroniclymphocyticleukemia,CLL)1例]及14例正常儿童外周血单核细胞EBV-DNA的含量,并结合患儿的临床表现、泼尼松敏感试验、诱导治疗完全缓解率,分析在儿童白血病患者血中EBV的感染及其临床意义。结果:35例儿童白血病患儿中8例(22.86%)有EBV感染。其中26例ALL中7例(26.92%)EBV感染,EBV-DNA含量为(5.14±6.91)×105copy/ml;8例ANLL中1例(12.5%)EBV感染,EBV-DNA含量为4.031×103copy/ml;1例CLL及14例正常对照儿童未检测到EBV-DNA的含量。EBV感染的儿童白血病患儿白细胞数[(144.64±46.41)×109/L]和肝脾肋下≥5cm发生率87.5%均高于非EBV感染患儿[(31.04±60.27)×109/L和7.4%,P<0.001]。感染EBV和非EBV感染的ALL患儿泼尼松疗效者分别为100%、26.32%(P=0.001);诱导治疗完全缓解率分别为28.57%、84.21%(P=0.003)。ANLL患儿中,1例感染EBV者的诱导治疗完全缓解率(100%)和早期复发率(100%)较未感染EBV的7例(84.21%,28.57%)高,二者无显著性差异(P>0.05)。结论:EBV感染组儿童白血病患儿肝脾肿大明显,外周血白细胞数明显高于非EBV感染者,EBV感染ALL组对泼尼松敏感试验反应差,诱导治疗获得完全缓解率低。 BACKGROUND & OBJECTIVE: Epstein-Barr virus (EBV)is associated with genesis of many human tumors. This study was to detect EBV infection in pediatric leukemia, and to explore its clinical significance. METHODS:EBV DNA in peripheral blood mononuclear cells in 35 pediatric leukemia patients, including 26 cases of acute lymphoblastic leukemia (ALL) (24 received initial treatment and 2 received retreatment), 8 cases of acute non-lymphocytic leukemia (ANLL) and 1 case of chronic lymphocytic leukemia (CLL), and in 14 healthy children was detected by fluorescent quantitative polymerase chain reaction (FQ-PCR). Its clinical significance was analyzed according to the clinical manifestations, prednisone sensitivity test, and complete remission (CR) rate after induction chemotherapy. RESULTS: EBV DNA was detected in 8 (22.86%) of the 35 pediatric leukemia patients. The positive rate of EBV DNA was 26.92% (7/26) in ALL with quantity of (5.144±6.91)×10^5 copies/ml, and 12.5% (1/8) in ANLL patients with quantity of 4.031×10^3 copies/ml. No EBV DNA was detected in CLL patients and healthy controls. The occurrence rates of peripheral leukocytosis and hepatosplenomegaly were significantly higher in the patients with EBV infection than in the patients without EBV infection (P 〈0.001). In ALL, the rate of no response to prednisone was significantly higher in the patients with EBV infection than in the patients without EBV infection (100% vs. 26.32%, P =0.001); CR rate after induction chemotherapy was significantly lower in the patients with EBV infection than in the patients without EBV infection (28.57% vs. 84.21%, P=0.003). In ANLL, the differences of CR rate and relapse rate were not significant between the patients with and without EBV infection (P= 0.5). CONCLUSIONS: Pediatric leukemia patients with EBV infection have higher incidence of peripheral leukocytosis and hepatosplenomegaly. ALL patients with EBV infection have poor prednisone response and low CR rate.
出处 《癌症》 SCIE CAS CSCD 北大核心 2007年第1期54-57,共4页 Chinese Journal of Cancer
关键词 Epstein—Barr病毒 儿童 白血病 荧光定量聚合酶链反应 Epstein-Barr virus Leukemia, children Fluorescent quantitative polymerase chain reaction
  • 相关文献

参考文献11

  • 1闵华庆,黄腾波.EB病毒与鼻咽癌相关的前瞻性观察[J].癌症,1991,10(5):367-370. 被引量:34
  • 2Telenti A, Marshall W F, Smith T F. Detection of Epstein-Barr virus by polymerase chain reaction [J]. J Clin Microbiol,1990,28(10) :2187-2190.
  • 3Young L S, Rickinson A B. Epstein-Barr virus: 40 years on[J]. Nat Rev Cancer, 2004,4(10):757-768.
  • 4顾龙君,孙桂香,卢新天,汤静燕,吴敏媛.小儿急性淋巴细胞白血病诊疗建议(第二次修订草案)[J].中华儿科杂志,1999,37(5):305-307. 被引量:307
  • 5Rickinson A B, Lee S P, Steven N M. Cytotoxic T lymphocyte responses to Epstein-Barr virus [J]. Curt Opin Immunol, 1996,8 (4) : 492-497.
  • 6Grogan E, Jenson H, Countryman J, et al. Transfection of a rearranged viral DNA fragment, Wzhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells [J]. Proc Natl Acad Sci USA, 1987,84(5):1332-1336.
  • 7Desjardin L E, Chen Y, Perkins M D, et al. Comparison of the ABI7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis [J]. J Clin Microbil, 1998,36(7) : 1964-1968.
  • 8Nemerow G R, Mold C, Schwend V K, et al. Identification of gp350 as the viral glyeoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d[J]. J Virol, 1987,61(5):1416-1420.
  • 9Ishikura H, Matsuno Y, Okano M, et al. A Japanese Burkitt's lymphoma with t(2;8) and EBNA [J]. Acta Pathol Jpn, 1986,36( 1 ) : 133-142.
  • 10Grimm T, Schneider S, Naschberger E, et al. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX [ J ]. Blood, 2005,105 (8) : 3263-3269.

二级参考文献1

  • 1闵华庆,潘甜美.鼻咽癌在广东分布与发病的特点[J]新医学,1978(12).

共引文献339

同被引文献61

  • 1郑国光,吴克复.人骨髓标本中人类疱疹病毒6型(HHV—6)抗原检测[J].中华血液学杂志,1993,14(5):237-239. 被引量:3
  • 2唐佩弦.造血干细胞研究发展历史引发的思考[J].中国实验血液学杂志,2005,13(5):723-732. 被引量:22
  • 3Ma XT, Song YH, Lu DM, et al. Human herpesvims 6 in hematologic diseases in China. Haematologica, 2000 ;85:458 -463
  • 4Ma XT, Song YH, Mu GF, et al. The role of human herpesvirus 6 in delayed engraftment in stem cell transplant patients in China. Haematologica, 2001 ;86:329 - 330
  • 5Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol, 2006 ; 16:251 - 261
  • 6Wade JC. Viral infections in patients with hematological malignancies. Hematology Am Soc Hematol Educ Program, 2006 ;368 - 374
  • 7Kawabata Y, Hirokawa M, Saitoh Y, et al. Late-onset fatal Epstein-Barr virus-associate hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia. Int J Hematol, 2006 ; 84 : 445 - 448
  • 8Roxas M. Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations. Alter Med Rev, 2006; 11 : 102 - 113
  • 9Yamashita N, Kimura H, Morishima T. Virological aspects of Epstein-Barr virus infections. Acta Med Okayama, 2005 ;59:239 - 246
  • 10Kikushige Y, Takase K, Miyamoto T, et al. Late relapse of acute myelogenous leukemia followed by Epstein-Barr virus-associated lymphoproliferative disease 11 years after allogenic bone marrow transplantation. Int J Hematol, 2006 ; 84 : 441 - 444

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部